The present invention relates to novel compounds, the use of said compounds as a medicament as well as for the manufacture of a medicament for treatment of disorders relating to the binding of galectin to receptors in a mammal. Said galectin is preferably a galectin-3.

 
Web www.patentalert.com

< Modified tumor necrosis factor-alpha converting enzyme and methods of use thereof

> Isolated nucleic acids encoding antipathogenic polypeptides and uses thereof

> AGPase promoter from rice and uses thereof
~ 00599